Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,580 public trials 828 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Active, Not Recruiting

SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies

NCT04684108

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +20 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Affiliated Beijing Chaoyang Hospital of Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Jishuitan Hostipal Beijing, Beijing Municipality, China
  • Shenzhen Second People's Hospital Shenzhen, Guangzhou, China
View all 14 locations
View Trial Details
Active, Not Recruiting

Compare Lenalidomide and Subcutaneous Daratumumab vs Lenalidomide and Dexamethasone in Frail Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy

NCT03993912

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Chru Jean Minjoz Besançon, France
  • Ch Blois Simone Veil Blois, France
  • Ch Fleyriat Bourg-en-Bresse, France
  • Chru Brest Site Hopital Morvan Brest, France
View all 23 locations
View Trial Details
Active, Not Recruiting

Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT04975997

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution - 035 Hot Springs, Arkansas, United States
  • Local Institution - 641 Cerritos, California, United States
  • Local Institution - 681 Fountain Valley, California, United States
  • Local Institution - 047 Los Angeles, California, United States
View all 259 locations
View Trial Details
Active, Not Recruiting

A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant

NCT05393804

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug

NCT05203679

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Nanfang Hospital Southern Medical University Guangzhou, Guangdong, China
  • The Second People's Hospital of Shenzhen Shenzhen, Guangdong, China
View Trial Details
Active, Not Recruiting

A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

NCT05552976

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Local Institution - 0046 Mobile, Alabama, United States
  • Local Institution - 0005 Cerritos, California, United States
  • Local Institution - 0190 Irvine, California, United States
  • Local Institution - 0187 Los Angeles, California, United States
View all 207 locations
View Trial Details

Related conditions